Skip to main content
SpringerLink
Log in

New Clinical Pharmacology Concepts in Pain Management

  • Chapter
Pain Management and Anesthesiology

Part of the book series: Developments in Critical Care Medicine and Anesthesiology ((DCCA,volume 33))

  • 91 Accesses

Abstract

The scientific foundation of clinical pharmacology has advanced remarkably in the last few decades, particularly in anesthesiology and pain management. While it is still not possible to account adequately for all sources of pharmacologic variability, modern pharmacokinetic- pharmacodynamic modeling techniques have enabled physicians to predict drug response with a quantitative exactness that was unimaginable in the early days of modern medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ: Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 1988;67:329–337.

    Article  CAS  PubMed  Google Scholar 

  2. Reilly CS, Wood AJJ, Wood M: Variability of fentanyl pharmaco kinetics in man: computer predicted plasma concentrations for three intravenous dosage regimens. Anaesthesia 1984;40:837–843.

    Article  Google Scholar 

  3. Owen H, McMillan V, Rogowski D: Postoperative pain therapy: A survey of patients#x2019; expectations and their experiences. Pain 1990;41:303–307.

    Article  CAS  PubMed  Google Scholar 

  4. Warfield CA, Kahn CH: Acute pain management: programs in U.S. hospitals and experiences and attitudes among U.S. adults. Anesthe-siology 1995; 83:1090–1094.

    CAS  Google Scholar 

  5. Crankshaw DP: Variability and anaesthetic agents. Anaesthetic Pharmacology Review 1994;2:271–279.

    CAS  Google Scholar 

  6. Peck CC, Barr WH, Benet LZ et al: Opportunities for integration of pharmacokinetics, pharmacodynamics and toxicokinetics in rational drug development. Clin Pharmacol Ther 1992;51:465–473.

    Article  CAS  PubMed  Google Scholar 

  7. Egan TD: Pharmacokinetics and rational intravenous drug selection and administration in anesthesia. Advances in Anesthesia 1995;12:363–388.

    Google Scholar 

  8. Ebling WF, Lee EN, Stanski DR: Understanding pharmacokinetics and pharmacodynamics through computer simulation: I. The com parative clinical profiles of fentanyl and alfentanil. Anesthesiology 1990; 72:650–658.

    CAS  Google Scholar 

  9. Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics and rational opioid selection. Anesthesiology 1991;74:53–63.

    Article  CAS  PubMed  Google Scholar 

  10. Hughes MA, Glass PSA, Jacobs JR: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anes thetic drugs. Anesthesiology 1992;76:334–341.

    Article  CAS  PubMed  Google Scholar 

  11. Youngs EJ, Shafer SL: Pharmacokinetic parameters relevant to recov ery from opioids. Anesthesiology 1994; 81:833–842.

    Article  CAS  PubMed  Google Scholar 

  12. Brunk SF, Delle M: Morphine metabolism in man. Clin Pharmacol Ther 1974;16:51–57.

    CAS  PubMed  Google Scholar 

  13. Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE: Morphine 6-glucuronide is a potent mu agonist. Life Sci 1987;41:2845–2849.

    Article  CAS  PubMed  Google Scholar 

  14. Portenoy RK, Khan E, Layman M, et al: Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine 6-glucuronide concentrations. Neurology 1991;41:1457–1461.

    Article  CAS  PubMed  Google Scholar 

  15. Portenoy RK, Howard TT, Inturrisi CE, Friedlander-Klar H, Foley KM: The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther 1992;51:422–431.

    Article  CAS  PubMed  Google Scholar 

  16. Osborne R, Joel S, Trew D, Slevin M: Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 1990;47:12–19.

    Article  CAS  PubMed  Google Scholar 

  17. Osborne RJ, Joel SP, Slevin ML: Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Br Med J 1986;292:1548–1549.

    Article  CAS  Google Scholar 

  18. D’Honneur G, Gilton A, Sandouk P, Scherrmann JM, et al: Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine: the influence of renal failure. Anesthesiology 1994;81:87–93.

    Article  PubMed  Google Scholar 

  19. Asatoor AM, London DR, Milne MD, Simenhoff ML: The excretion of pethidine and its derivatives. Br J Pharmacol 1963;20:285–298.

    CAS  Google Scholar 

  20. Shochet RB, Murray GB: Neuropsychiatric toxicity of meperidine. J Intensive Care Med 1988;3:246–252.

    Article  Google Scholar 

  21. Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, Reidenberg MM: Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983;13:180–185.

    Article  CAS  PubMed  Google Scholar 

  22. Szeto HH, Inturrisi CE, Houde R, et al. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Ann Intern Med 1977;86:738–741.

    CAS  PubMed  Google Scholar 

  23. Bailey JM: Technique for quantifying the duration of intravenous anesthetic effect. Anesthesiology 1995;83:1095–1103.

    Article  CAS  PubMed  Google Scholar 

  24. Mather LE: Pharmacokinetic and pharmacodynamic profiles of opioid analgesics: a sameness amongst equals? Pain 1990; 43:3–6.

    Article  CAS  PubMed  Google Scholar 

  25. Jacobs JR, Reves JG: Effect site equilibration time is a determinant of induction dose requirement. Anesth Analg 1993; 76:1–6.

    Article  CAS  PubMed  Google Scholar 

  26. Verotta D, Sheiner LB: Simultaneous modeling of pharmacokinetics and pharmacodynamics: an improved algorithm. CABIOS 1987; 3:345–349.

    CAS  PubMed  Google Scholar 

  27. Mason S: The origin of chirality in nature. Trends Pharmacol Sci 1986;7:20–23.

    Article  CAS  Google Scholar 

  28. Hegstrom RA, Konderpudi DK: The handedness of the universe. Sci American 1990;262:98–105.

    Article  Google Scholar 

  29. Morrison RT, Boyd RN. Organic chemistry. 3rd Edition. Boston: Allyn and Bacon, 1973.

    Google Scholar 

  30. Testa B: Mechanisms of chiral recognition in xenobiotic metabolism and drug-receptor interaction. Chirality 1989;l:7–9.

    Article  Google Scholar 

  31. Ariens EJ: Chirality in bioactive agents and its pitfalls. Trends Pharmacol Sci 1986;7:200–205.

    Article  CAS  Google Scholar 

  32. Tucker GT, Lennard MS: Enantiomer specific pharmacokinetics. Pharmac Ther 1990;45:309–329.

    Article  CAS  Google Scholar 

  33. Williams KM: Chirality: pharmacokinetics and pharmacodynamics in 3 dimensions. Clin Exp Pharmacol Physiol 1989:16:465–470.

    Article  CAS  PubMed  Google Scholar 

  34. Drayer DE: Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview. Clin Pharmacol Ther 1986;40:125–133.

    Article  CAS  PubMed  Google Scholar 

  35. Lee EJD, Williams KM: Chirality. Clinical pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 1990;18:339–345.

    CAS  Google Scholar 

  36. Wahlstrom G, Norberg L: A comparative investigation in the rat of the anesthetic effects of the isomers of two barbiturates. Brain Res 1984;310:261–267.

    Article  CAS  PubMed  Google Scholar 

  37. Kaiser DG, van Geissen GJ, Reisher RJ, Wechter WJ. Isomeric inver sion of ibuprofen (R)-enantiomer in humans. J Pharma Sci 1976;65:269–273.

    Article  CAS  Google Scholar 

  38. O’Reilly RA, Trager WF, Rettie AE, Goulart DA: Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans. Clin Pharmacol Ther 1987;42:290–294.

    Article  PubMed  Google Scholar 

  39. Whelan E, Wood AJ, Koshakji R, Shay S, Wood M: Halothane inhibition in propranolol metabolism is stereoselective. Anesthesiology 1989;71:561–564.

    Article  CAS  PubMed  Google Scholar 

  40. Ariens EJ: Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 1984;26:663–668.

    Article  CAS  PubMed  Google Scholar 

  41. Egan TD: Chirality and anesthetic pharmacology: joining hands with the medicinal chemists. Anesth Analg (in press)

    Google Scholar 

  42. Nation RL: Chirality in new drug development-clinical pharma cokinetic considerations. Clin Pharmacokinet 1994;27:249–255.

    Article  CAS  PubMed  Google Scholar 

  43. Egan TD: Remifentanil pharmacokinetics and pharmacodynamics: a preliminary appraisal. Clin Pharmacokinet 1995;29:80–94.

    Article  CAS  PubMed  Google Scholar 

  44. Egan TD, Lemmens HJM, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993;79:881–892.

    Article  CAS  PubMed  Google Scholar 

  45. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL: remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996;4:821–833.

    Article  Google Scholar 

  46. Egan TD: Intravenous drug delivery systems: toward an intravenous vaporizer. J Clin Anesth 8:8S–14S, 1996.

    Article  CAS  PubMed  Google Scholar 

  47. Schwilden H: A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol 1981;20:379–386.

    Article  CAS  PubMed  Google Scholar 

  48. Shafer SL, Varvel JR, Aziz N, Scott JC: Pharmacokinetics of fentanyl administered by computer controlled infusion pump. Anesthesiology 1990;73:1091–1102.

    Article  CAS  PubMed  Google Scholar 

  49. van den Nieuwenhuyzen MCO, Engbers FHM, Burm AGL, Vletter AA, van Kleef JW, Bovill JG: Computer controlled infusion of alfen tanil versus patient controlled administration of morphine for postoperative analgesia: a double blind randomized trail. Anesth Analg 1995;81:671–679.

    PubMed  Google Scholar 

Download references

Authors
  1. T. D. Egan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, The University of Utah Medical School, Salt Lake City, Utah, USA

    Michael A. Ashburn , Perry G. Fine  & Theodore H. Stanley ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Egan, T.D. (1998). New Clinical Pharmacology Concepts in Pain Management. In: Ashburn, M.A., Fine, P.G., Stanley, T.H. (eds) Pain Management and Anesthesiology. Developments in Critical Care Medicine and Anesthesiology, vol 33. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5145-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5145-0_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6162-9

  • Online ISBN: 978-94-011-5145-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation